期刊文献+

不同救治手段对急性心肌梗死转归的影响

The effects of different remedies on acute myocardial infarction
下载PDF
导出
摘要 目的对比分析12h内来院的急性心肌梗死(AMI)患者采用溶栓,直接冠脉成形术和转院后急诊冠脉成形术治疗方法对AMI患者预后的影响。方法将2004年1月-2005年12月来院的AMI12h内患者采取连续入组的方式分为溶栓治疗组(32例)和直接冠脉成形术治疗组(63例),以及外院转院于12h内行急诊冠脉成形术治疗组(25例),比较3组患者在院期间和出院后1年转归的差别。结果与直接冠脉成形术和转院后急诊冠脉成形术相比,溶栓组到院至再通时间间隔最短,分别平均为(1.1±0.2)h、(2.3±1.0)h和(2.1±1.1)h,(P<0.01),病死率(分别为6.3%、3.2%和4.0%)和1年后病死率(分别为12.5%、4.8%和8.0%)均未达统计学意义,溶栓组非致死性再梗死的发生率显著高于PCI组(分别为18.8%和4.5%,P<0.05)。结论AMI的救治关键是尽早开通罪犯血管,转院治疗也是较为安全有效的治疗方式。 Objective To investigate the different treatment effects of intravenous thrombolysis vs primary coronary angioplasty and interhospital transfer for primary coronary angioplasty in acute myocardial infarction within 12 hours after onset. Methods During January 2004 to December 2005, 63 consecutive patients with acute myocardial infarction admitted directly for primary PCI and 25 patients transferred from other hospitals for primary PCI were compared with 32 patients treated with intravenous thrombolysis. Each patients arrived at hospital within 12 h from chest pain onset. T-test and Chi-square test were used to analyze the rate of mortality, re-infarction, heart failure in-hospital and 1-year latter. Results Among the 3 groups, for group of intravenous thrombolysis, time interval from arriving to having reflow was the shortest (1.1 ± 0.2 h vs 2.3 ± 1.0 h vs 2.1 ± 1.1 h, P 〈 0.01), the mortalities in hospital (6.3% vs 3.2% vs 4.0%) and 1-year follow up (12.5% vs 4.8% vs 8.0% )were highest in spite of no statistic difference. After 1 year, the rate of reinfarction in intravenous thrombolysis group is higher than that in PCI group (18.8% vs 4.5%, P 〈 0.05). Conclusions The key point of AMI remedy is to open the criminal vessel as fast as possible. Interhospital transfer for PCI is feasible and safe.(J Intervent Radiol, 2007, 16: 630-633)
出处 《介入放射学杂志》 CSCD 2007年第9期630-633,共4页 Journal of Interventional Radiology
关键词 急性心肌梗死 直接冠脉成形术 冠脉成形术 溶栓 Acute myocardial infarction Primary coronary angioplasty Interhospital transfer Intervenous thrombolysis
  • 相关文献

参考文献2

二级参考文献26

  • 1Ryan TJ, Antman EM, Brooks NH,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coil Cardiol, 1999,34:890-911.
  • 2Zahn R, Schiele R, Schneider S, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol,2001,37 :1827-1835.
  • 3Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet,2002,359:373-377.
  • 4Krumholtz H, Murillo JE, Chen J, et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA,1997,277 : 1683-1688.
  • 5Anderson JL,Karagounis LA,Becker LC,et al.TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction:ventriculographic,enzymatic,and electrocardiographic evidence from the TEAM-3 study[J].Circulation,1993,87:1829-1839.
  • 6Stone GW,Brodie BR,Griffin JJ,et al.Prospective,multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction:in-hospital and 30-day results of the PAMI stent pilot trial[J].J Am Coll Cardiol,1998,31:23-30.
  • 7Gibson CM,Ryan K,Sparano A,et al.Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results[J].Am Heart J,1999,37:1179-1184.
  • 8Gibson CM,Cannon CP,Daley WL,et al.TIMI frame count:a quantitative method of assessing coronary artery flow [J].Circulation,1996,93:879-888.
  • 9Gibson CM,Murphy SA,Rizzo MJ,et al.Relationship between TIMI frame count and clinical outcomes after thrombolytic administration[J].Circulation,1999,99:1945-1950.
  • 10Gibson CM,Dotani MI,Murphy SA,et al.Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial.Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis [J].Am Heart J,2002,144:130-135.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部